Refine Results

Authors: Marc Edwards & Victor Weigman As we celebrate the efforts of so many researchers, providers, patients, and advocates on World Diabetes Day, we have much to be excited about today.  New discoveries are being made and new hope is being given to patients living with diabetes across the globe. However, this excitement is tempered by some very sobering statistics: Worldwide prevalence figures estimate that there were 415 million adults living with Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) in 2015 and that by 2035, this number will have risen to 642 million, especially in middle and low income families.1  Diabetes affects 30 million children and adults in the US (1 in 11... Read More

The theme for this year’s World Immunization Week, “#VaccinesWork”, rings true for the many diseases from which vaccines are protecting people of all ages across the globe.  Yet, there are more diseases, for which vaccines may work, once they make it through all the development phases into the hands of the patients who need them.  For example, drug resistance and large populations at-risk contribute to the pressing need for development of a malaria vaccine that works. Malaria – Still a deadly threat Malaria has been, and still is, among the world’s deadliest diseases. King Tut and Genghis Khan died from malaria, as may up to half of the people who have ever lived.1 There were 212 million... Read More

Topics

Vaccines

This month, during World Immunization Week (April 24-30, 2017), we recognize immunizations as one of the world’s most important and effective health interventions, responsible for saving countless people of all ages from disease and death. The theme for 2017 World Immunization Week is #VaccinesWork.  Over the last 3 years, Ebola vaccine research has transitioned from lightly funded research in the public health arena to both biotech companies and large pharma.  New approaches to vaccine design have been brought to the mainstream allowing them to address other emerging and established infectious diseases. Remarkably, new vaccine designs for Ebola are already being applied to the Zika... Read More

Topics

Vaccines , Research and Development , End-to-End Services , Central Laboratories